We aimed to compare SPECT/CT and lymphoscintigraphy on overall and bilateral sentinel lymph node (SLN) detection in cervical cancer patients. Methods: A systematic search was performed on August 1, 2014, in PubMed, Embase, Scopus, and the Cochrane library. The syntax was based on synonyms of the terms cervical cancer, SPECT/CT, and lymphoscintigraphy. Retrieved articles were screened on their title/abstract and considered eligible when an SLN procedure was performed using both imaging modalities and if detection results were reported. Two independent reviewers assessed all included studies on methodologic quality using QUADAS-2. Studies were pooled on their odds ratios (ORs) with a randomeffects model. Results: The search yielded 962 unique articles, of which 8 were ultimately included. The studies were recent retrospective or prospective cohort studies of limited size (n 5 7-51) but sufficient methodologic quality. The median overall detection ($1 SLN in a patient) was 98.6% for SPECT/CT (range, 92.2%-100.0%) and 85.3% for lymphoscintigraphy (range, 70.0%-100.0%). This corresponded to a pooled overall SLN detection OR of 2.5 (95% CI, 1.2-5.3) in favor of SPECT/CT. The reported median bilateral detection ($1 SLN in each hemipelvis) was 69.0% for SPECT/CT (range, 62.7%-79.3%) and 66.7% for lymphoscintigraphy (range, 56.9%-75.8%), yielding a pooled OR of 1.2 (95% CI, 0.7-2.1). No significant difference in the number of visualized SLNs was observed at a pooled ratio of 1.2 (95% CI, 0.9-1.6). In recent years, the sentinel lymph node (SLN) procedure has been increasingly adopted in the staging of cervical cancer patients eligible for surgery. The SLN procedure allows for individualized treatment decisions by accurately ascertaining the lymph node status before radical surgery takes place (1), with the possibility of excluding fertility-sparing surgery or replacing a radical hysterectomy with chemoradiotherapy in patients with tumorpositive lymph nodes.Besides blue dye, the colloid-bound radionuclide 99m Tc is commonly added as a second tracer and has been shown to improve intraoperative SLN detection (2). A second advantage of this tracer is that preoperative lymphatic mapping by either SPECT/ CT or planar lymphoscintigraphy becomes possible, enabling prediction of the surgical detectability and number of SLNs in an individual patient. This ability aids the surgeon in performing a more direct SLN resection with less disruption of the lymphatic architecture when compared with a full retroperitoneal exploration (3-5).Although SPECT/CT is associated with both increased upfront cost and ionizing radiation, it provides a cross-sectional anatomic reference that allows for accurate 3-dimensional SLN localization, which is considered an important advantage over planar lymphoscintigraphy (5-9). Both SPECT/CT and lymphoscintigraphy should ideally have a high SLN detection ability, which largely determines the clinical value of the entire procedure.On the basis of a systematic search of the literature, we compared detection of ...